New England Research & Management’s Broadcom AVGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.22M Sell
11,176
-195
-2% -$78.2K 1.64% 15
2026
Q1
$3.52M Buy
11,371
+616
+6% +$203K 1.49% 15
2025
Q4
$3.72M Buy
10,755
+1,120
+12% +$401K 1.63% 14
2025
Q3
$3.18M Sell
9,635
-100
-1% -$30.7K 1.46% 16
2025
Q2
$2.68M Sell
9,735
-54
-0.6% -$11.7K 1.27% 21
2025
Q1
$1.64M Sell
9,789
-7,581
-44% -$1.6M 0.83% 36
2024
Q4
$4.03M Buy
17,370
+15
+0.1% +$2.77K 2.05% 8
2024
Q3
$2.99M Sell
17,355
-355
-2% -$56.9K 1.41% 14
2024
Q2
$2.84M Buy
17,710
+6,100
+53% +$855K 1.37% 14
2024
Q1
$1.54M Buy
+11,610
New +$1.44M 0.76% 45
2023
Q4
Sell
-14,360
Closed -$1.19M 157
2023
Q3
$1.19M Buy
+14,360
New +$1.24M 0.68% 54
2020
Q3
Sell
-12,500
Closed -$395K 137
2020
Q2
$395K Buy
12,500
+500
+4% +$14K 0.28% 104
2020
Q1
$285K Buy
+12,000
New +$338K 0.24% 111
2019
Q3
Sell
-8,000
Closed -$230K 161
2019
Q2
$230K Buy
+8,000
New +$233K 0.16% 150

Other funds holding AVGO

New England Research & Management's AVGO Position: Q2 2026 in Review

New England Research & Management reduced its Broadcom (AVGO) stake by 1.7% in Q2 2026, selling an estimated $78.2K and leaving 11,176 shares worth $4.22M. The position accounts for 1.64% of the portfolio, ranked #15.

New England Research & Management first reported a position in AVGO in Q2 2019 and has held it in 14 quarters since. 2,338 funds tracked by Wall St. Rank hold AVGO as of Q2 2026.

  • New England Research & Management held 11,176 shares of Broadcom worth $4.22M as of Q2 2026.
  • New England Research & Management sold 195 Broadcom shares in Q2 2026, an estimated $78.2K.
  • Broadcom made up 1.64% of New England Research & Management's portfolio in Q2 2026, its #15 holding.
  • New England Research & Management first reported a position in Broadcom in Q2 2019 and has held it in 14 quarters since.
  • 2,338 funds tracked by Wall St. Rank held Broadcom as of Q2 2026.

Based on New England Research & Management's 13F filing for Q2 2026, filed 9 Jul 2026.